Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

Benelli, Roberto; Costa, Delfina; Mastracci, Luca; Grillo, Federica; Olsen, Mark Jon; Barboro, Paola; Poggi, Alessandro; Ferrari, Nicoletta

doi:10.3390/cancers12051226

Open AccessErratum

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

¹

SSD Oncologia Molecolare e Angiogenesi, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy

²

Anatomia Patologica, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy

³

Anatomia patologica, Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università di Genova, 16132 Genova, Italy

⁴

Department of Pharmaceutical Sciences, Midwestern University, Campus Glendale, Glendale, AZ 85308, USA

⁵

Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, largo Rosanna Benzi 10, 16132 Genova, Italy

^*

Author to whom correspondence should be addressed.

Cancers 2020, 12(5), 1226; https://doi.org/10.3390/cancers12051226

Submission received: 12 May 2020 / Accepted: 12 May 2020 / Published: 13 May 2020

Download Versions Notes

The authors wish to make the following corrections to this paper [1]:

Please note that Midwestern University signed the technology transfer agreement very recently, this is the reason why we forgot to modify the conflict of interest statement in the last revision of the manuscript.

The “Conflicts of Interest” statement should be changed to:

Conflicts of Interest: M.J.O. is the CEO of Crenae Therapeutics which has licensed ASPH inhibitor technologies from Midwestern University. The other authors declare no conflict of interest.

The authors would like to apologize for any inconvenience caused to the readers by these changes.

Reference

Benelli, R.; Costa, D.; Mastracci, L.; Grillo, F.; Olsen, M.J.; Barboro, P.; Poggi, A.; Ferrari, N. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. [Google Scholar] [CrossRef] [PubMed] [Green Version]

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Benelli, R.; Costa, D.; Mastracci, L.; Grillo, F.; Olsen, M.J.; Barboro, P.; Poggi, A.; Ferrari, N. Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers 2020, 12, 1226. https://doi.org/10.3390/cancers12051226

AMA Style

Benelli R, Costa D, Mastracci L, Grillo F, Olsen MJ, Barboro P, Poggi A, Ferrari N. Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers. 2020; 12(5):1226. https://doi.org/10.3390/cancers12051226

Chicago/Turabian Style

Benelli, Roberto, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, and Nicoletta Ferrari. 2020. "Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971" Cancers 12, no. 5: 1226. https://doi.org/10.3390/cancers12051226

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI